Medicover Q1: Spectacular results
Research Note
2021-04-13
16:55
Redeye maintains its base case of SEK 205 per share, at this time. Medicover delivered impressive results for Q1: revenues, EBITDA and EBIT were above our expectations. We are bracing ourselves for an even better Q2.
GA
Gergana Almquist
Disclosures and disclaimers